Logo image of LPSN

LIVEPERSON INC (LPSN) Stock Fundamental Analysis

NASDAQ:LPSN - Nasdaq - US5381461012 - Common Stock - Currency: USD

1.01  +0.05 (+5.73%)

After market: 1.03 +0.02 (+1.98%)

Fundamental Rating

1

Taking everything into account, LPSN scores 1 out of 10 in our fundamental rating. LPSN was compared to 282 industry peers in the Software industry. LPSN may be in some trouble as it scores bad on both profitability and health. LPSN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LPSN had negative earnings in the past year.
LPSN had a negative operating cash flow in the past year.
LPSN had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LPSN reported negative operating cash flow in multiple years.
LPSN Yearly Net Income VS EBIT VS OCF VS FCFLPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of LPSN (-18.91%) is worse than 69.86% of its industry peers.
Industry RankSector Rank
ROA -18.91%
ROE N/A
ROIC N/A
ROA(3y)-18.28%
ROA(5y)-15.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LPSN Yearly ROA, ROE, ROICLPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

LPSN's Gross Margin of 71.87% is in line compared to the rest of the industry. LPSN outperforms 58.51% of its industry peers.
In the last couple of years the Gross Margin of LPSN has remained more or less at the same level.
LPSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.73%
GM growth 5Y-0.79%
LPSN Yearly Profit, Operating, Gross MarginsLPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

1

2. Health

2.1 Basic Checks

LPSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LPSN has more shares outstanding
LPSN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LPSN has a worse debt to assets ratio.
LPSN Yearly Shares OutstandingLPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LPSN Yearly Total Debt VS Total AssetsLPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -1.91, we must say that LPSN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.91, LPSN is not doing good in the industry: 78.01% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.91
ROIC/WACCN/A
WACC2.79%
LPSN Yearly LT Debt VS Equity VS FCFLPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

LPSN has a Current Ratio of 1.65. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
LPSN's Current ratio of 1.65 is in line compared to the rest of the industry. LPSN outperforms 51.06% of its industry peers.
LPSN has a Quick Ratio of 1.65. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.65, LPSN is in line with its industry, outperforming 51.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
LPSN Yearly Current Assets VS Current LiabilitesLPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

LPSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.72%, which is quite good.
LPSN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.03%.
LPSN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.39% yearly.
EPS 1Y (TTM)9.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-23.03%
Revenue growth 3Y-12.7%
Revenue growth 5Y1.39%
Sales Q2Q%-24.02%

3.2 Future

Based on estimates for the next years, LPSN will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.81% on average per year.
LPSN is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -10.97% yearly.
EPS Next Y39.95%
EPS Next 2Y17.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-21.38%
Revenue Next 2Y-10.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LPSN Yearly Revenue VS EstimatesLPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
LPSN Yearly EPS VS EstimatesLPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LPSN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LPSN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LPSN Price Earnings VS Forward Price EarningsLPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LPSN Per share dataLPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

LPSN's earnings are expected to grow with 17.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.81%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LPSN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIVEPERSON INC

NASDAQ:LPSN (7/17/2025, 5:33:30 PM)

After market: 1.03 +0.02 (+1.98%)

1.01

+0.05 (+5.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners18.14%
Inst Owner Change0%
Ins Owners2.28%
Ins Owner Change-0.17%
Market Cap94.79M
Analysts48.89
Price Target0.94 (-6.93%)
Short Float %13.77%
Short Ratio8.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-210.75%
Min EPS beat(2)-460.85%
Max EPS beat(2)39.36%
EPS beat(4)2
Avg EPS beat(4)-32.72%
Min EPS beat(4)-460.85%
Max EPS beat(4)331.92%
EPS beat(8)3
Avg EPS beat(8)-41.16%
EPS beat(12)5
Avg EPS beat(12)-24.82%
EPS beat(16)9
Avg EPS beat(16)-8.04%
Revenue beat(2)1
Avg Revenue beat(2)2.01%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)5.3%
Revenue beat(4)3
Avg Revenue beat(4)1.89%
Min Revenue beat(4)-1.28%
Max Revenue beat(4)5.3%
Revenue beat(8)5
Avg Revenue beat(8)1.21%
Revenue beat(12)6
Avg Revenue beat(12)0.18%
Revenue beat(16)8
Avg Revenue beat(16)0.18%
PT rev (1m)0%
PT rev (3m)-3.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-101.85%
EPS NY rev (1m)-1.02%
EPS NY rev (3m)-38.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.91%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-2.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.3
EYN/A
EPS(NY)-0.95
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS3.11
BVpS-0.8
TBVpS-3.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.91%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.87%
FCFM N/A
ROA(3y)-18.28%
ROA(5y)-15.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.73%
GM growth 5Y-0.79%
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.13%
Cap/Sales 6.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z -1.91
F-Score3
WACC2.79%
ROIC/WACCN/A
Cap/Depr(3y)73.49%
Cap/Depr(5y)106.31%
Cap/Sales(3y)9.03%
Cap/Sales(5y)9.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y39.95%
EPS Next 2Y17.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.03%
Revenue growth 3Y-12.7%
Revenue growth 5Y1.39%
Sales Q2Q%-24.02%
Revenue Next Year-21.38%
Revenue Next 2Y-10.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year72.76%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.2%
OCF growth 3YN/A
OCF growth 5YN/A